BEYOND MEAT ALERT: Bragar Eagel & Squire, P.C. is Investigating Beyond Meat, Inc. on Behalf of Beyond Meat Stockholders and Encourages Investors to Contact the Firm

BEYOND MEAT ALERT: Bragar Eagel & Squire, P.C. is Investigating Beyond Meat, Inc. on Behalf of Beyond Meat Stockholders and Encourages Investors to Contact the Firm GlobeNewswire November 06, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Beyond Meat (BYND) To Contact Him Directly To Discuss Their […]

Lost Money on Hormel Foods Corporation (HRL)? Contact Levi & Korsinsky About Fraud Investigation

NEW YORK, NY / ACCESS Newswire / November 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Hormel Foods Corporation ("Hormel Foods Corporation") (NYSE:HRL) concerning possible violations of federal securities laws. The Wall Street Journal published an article on October 29, 2025, entitled "Hormel Cuts Forecast on Price Pressure,

Lost Money on F5, Inc. (FFIV)? Contact Levi & Korsinsky to Protect Your Rights

NEW YORK, NY / ACCESS Newswire / November 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of F5, Inc. ("F5, Inc.") (NASDAQ:FFIV) concerning possible violations of federal securities laws. F5 disclosed on October 15, 2025, that the company learned on August 9, 2025 "that a highly sophisticated nation-state threat

Shareholders of Fly-E Group, Inc. (FLYE): Protect Your Rights Before November 10, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 6, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fly-e-group-inc-lawsuit-submission-form?prid=175891&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akebia Therapeutics, Inc. – AKBA

NEW YORK, NY / ACCESS Newswire / November 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Akebia Therapeutics, Inc. ("Akebia" or the "Company") (NASDAQ:AKBA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Akebia and certain of its officers and/or directors

EASY HONDA IS REWARDING A LOCAL VETERAN WITH A NEW HONDA

Through their Happiness Project Initiative, in partnership with NextOp, Easy Honda is awarding a veteran with a new vehicle on Veterans Day, November 11th, 2025. Easy Honda introduced the Vehicles for Vets program and asked NextOp, a Houston-based non-profit whose mission is to help veterans find careers when their military service is complete, to nominate

Investigation Underway: Stride, Inc. (LRN) – Contact Levi & Korsinsky Over Securities Law Violations

NEW YORK, NY / ACCESS Newswire / November 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE:LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers

Novel Pipeline Activity Signals Hope in Systemic Sclerosis, as Rheumatologists Anticipate First Real Therapeutic Advances in Years

EXTON, PA, Nov. 06, 2025 (GLOBE NEWSWIRE) — According to the latest Market Dynamix(TM): Systemic Sclerosis (US) 2025 study from Spherix Global Insights, the treatment landscape for systemic sclerosis (SSc) is poised for meaningful evolution. Nearly all surveyed rheumatologists continue to describe an extremely high unmet need for new pharmacologic options, yet confidence in the

Novel Pipeline Activity Signals Hope in Systemic Sclerosis, as Rheumatologists Anticipate First Real Therapeutic Advances in Years

Novel Pipeline Activity Signals Hope in Systemic Sclerosis, as Rheumatologists Anticipate First Real Therapeutic Advances in Years Familiarity with AstraZeneca's Saphnelo and enthusiasm for next-generation biologics signal increasing optimism, though CAR T-cell therapy divides opinion amid safety and access concerns, according to Spherix Global Insights GlobeNewswire November 06, 2025 EXTON, PA, Nov. 06, 2025 (GLOBE

American Battery Technology Company Selected to Recycle Batteries from the Largest Lithium-Ion Battery Cleanup in US History, $30 Million Estimated Project Proceeds

(NASDAQ:ABAT), Reno, Nev., Nov. 06, 2025 (GLOBE NEWSWIRE) — American Battery Technology Company (NASDAQ: ABAT), an integrated critical battery materials company commercializing both its primary battery critical mineral manufacturing and secondary lithium-ion battery recycling facilities, has been contracted for and approved by the U.S. Environmental Protection Agency (EPA) to recycle the end-of-life lithium-ion batteries from

Scroll to Top